Table 2.
Relative 5-year survival rates of rhabdomyosarcomas in SEER registries for the diagnostic period 1996–2000.
| SEER 9 registries | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| RMS Overall | Embryonal RMS |
Alveolar RMS |
|||||||
| No. (%) | 5-year Survival Rate (%)*¶ |
95% CI† | No. (%) | 5-year Survival Rate (%) *¶ |
95% CI† | No. (%) | 5-year Survival Rate (%) *¶ |
95% CI† | |
| Total | 166 (100.0%) | 61.8§∥ | (54.3 – 69.2) | 91 (100.0%) | 73.4 | (64.2 – 82.6) | 50 (100.0%) | 47.8 | (33.9 – 61.7) |
| Sex | |||||||||
| Male | 96 (57.8%) | 64.4§∥ | (54.8 – 74.1) | 53 (58.2%) | 73.3§ | (61.2 – 85.4) | 27 (54.0%) | 55.6 | (36.8 – 74.4) |
| Female | 70 (42.2%) | 58.0 | (46.3 – 69.7) | 38 (41.8%) | 73.4 | (59.1 – 87.6) | 23 (46.0%) | 37.9 | (17.6 – 58.2) |
| Age | |||||||||
| 0–4 years | 65 (39.2%) | 70.5 | (59.3 – 81.8) | 42 (46.2%) | 76.0 | (62.9 – 89.1) | 16 (32.0%) | 68.1 | (44.8 – 91.5) |
| 5–9 years | 46 (27.7%) | 60.2 | (45.8 – 74.5) | 24 (26.4%) | 78.5§∥ | (61.8 – 95.3) | 16 (32.0%) | 37.5 | (13.8 – 61.3) |
| 10–14 years | 27 (16.3%) | 59.3 | (40.8 – 77.9) | 11 (12.1%) | 72.8 | (46.4 – 99.2) | 10 (20.0%) | 40.0 | (9.6 – 70.5) |
| 15–19 years | 28 (16.9%) | 46.6 | (28.0 – 65.1) | 14 (15.4%) | 57.3 | (31.3 – 83.3) | 8 (16.0%) | 37.6§∥ | (3.9 – 71.2) |
| Race | |||||||||
| White | 121 (72.9%) | 59.0∥ | (50.1 – 67.8) | 68 (74.7%) | 73.0§ | (62.3 – 83.8) | 35 (70.0%) | 39.4 | (23.0 – 55.8) |
| Black | 30 (18.1%) | 66.8 | (49.9 – 83.8) | 14 (15.4%) | 78.7 | (57.1 – 100‡) | 10 (20.0%) | 50.1 | (19.0 – 81.2) |
| American Indian/ Alaskan Native, Asian/Pacific Islander |
14 (8.4%) | 71.5 | (47.8 – 95.2) | 9 (9.9%) | 66.7 | (35.9 – 97.6) | 4 (8.0%) | 100.0 | (100.0 – 100.0) |
|
SEER 13 registries | |||||||||
| RMS Overall |
Embryonal RMS |
Alveolar RMS |
|||||||
| No. (%) |
5-year Survival Rate (%)* |
95% CI† | No. (%) |
5-year Survival Rate (%)* |
95% CI† | No. (%) |
5-year Survival Rate (%)* |
95% CI† | |
| Ethnicity | |||||||||
| Hispanic | 48 (100.0%) | 50.2 | (35.7 – 64.6) | 28 (58.3%) | 57.3** | (38.9 – 75.7) | 13 (27.1%) | 33.4 | (6.7 – 60.1) |
*
5-year relative survival rate calculated via actuarial method.
†
95% CI: 95% confidence interval
‡
Upper confidence level truncated at 100%.
§
Survival curve is significantly different from 1976–1980 curve (p<0.05).
∥
1986–1990 survival curve is significantly different from 1976–1980 curve (p<0.05).
¶
None of the 1996–2000 survival curves is significantly different from 1986–1990 curve.
**
Survival curve is statistically significantly different than the curve among non-Hispanic white children (p<0.02).